Skip to main content
Caplight Logo









Eaglenos Sciences, Inc.

Eaglenos Sciences, Inc.

Private
NanjingHealthcare & Life Scienceshttps://www.eaglenos.com/

Last Round

Series A

May 29, 2023

Total Funding Raised

$21.1M

Company Overview

Eaglenos Sciences, Inc. is a medical devices company that develops, manufactures, and markets diagnostic devices for home care and point-of-care testing, including blood gas analyzers, electrolyte analyzers, and continuous monitoring systems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care testingPOCTblood gas analyzermicrofluidicscontinuous glucose monitoringCGMelectrolyte analyzermedical diagnosticsbedside testinghealth management appwearable health monitorcritical care diagnosticstest cartridgeshome health monitoringmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eaglenos Sciences, Inc. Comparables

Compare Eaglenos Sciences, Inc. with similar companies based on industry and business-model similarity.

Eaglenos Sciences, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chengdu Seamaty Technology Co., Ltd.
86%
Abbott Laboratories
83%
LifeHealth, LLC
79%

Eaglenos Sciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 29, 2023

Eaglenos Sciences, Inc. Investors

Notable investors and investment history

Eaglenos Sciences, Inc. investors
InvestorRounds
Bencao CapitalSeries A
Huatai Zijin InvestmentSeries A
InnoMed CapitalSeries A
Grand Yangtze CapitalSeries A

Eaglenos Sciences, Inc. Filings

Explore SEC and related filing metadata, where available.

Eaglenos Sciences, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eaglenos Sciences, Inc.'s valuation, stock price, and market status.

Is Eaglenos Sciences, Inc. a public or private company?

Eaglenos Sciences, Inc. is a private company.

What is the current stock price of Eaglenos Sciences, Inc.?

Eaglenos Sciences, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Eaglenos Sciences, Inc. worth (valuation)?

Valuation information for Eaglenos Sciences, Inc. is not publicly available.

Can I buy Eaglenos Sciences, Inc. stock?

Eaglenos Sciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eaglenos Sciences, Inc.'s last funding round?

Eaglenos Sciences, Inc.'s most recent funding round was Series A on May 29, 2023.

Who are the main investors in Eaglenos Sciences, Inc.?

Key investors in Eaglenos Sciences, Inc. include Bencao Capital, Huatai Zijin Investment, InnoMed Capital, Grand Yangtze Capital.

Will Eaglenos Sciences, Inc. IPO soon?

No public IPO plans have been announced for Eaglenos Sciences, Inc..

How can I track Eaglenos Sciences, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eaglenos Sciences, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNanjing
Employee Range52
Year Founded2018
Last FundingMay 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?